Abstract
<title>Abstract</title> Background The widespread use of accurate real-time RT-PCR tests for community individuals is a critical approach to managing the disease and reducing COVID-19 transmission effectively. In addition, serological ELISA assays are another essential tool for detecting and/or quantifying SARS-CoV-2 IgG and IgM antibodies or for screening for SARS-CoV-2 infection. Objectives The objective of the current study is to develop an in-house multiplex real-time RT-qPCR kit for molecular detection of SARS-CoV-2 <italic>N and E genes</italic> . Materials and methods A total of 100 samples from the Central Public Health Laboratory were analyzed: 50 tested positive for SARS-CoV-2 RNA and 50 tested negative. Results The in-house multiplex qPCR assay showed a significant association at P value 0.01 between the in-house N gene CT Value and the commercial N gene CT value, but there was no significant association at P value 0.09 between the in-house E gene CT Value and the commercial E gene CT Value. The in-house-designed RT-qPCR-E gene had a sensitivity of 96% and a specificity of 98.11%. The in-house-designed RT-qPCR N gene had a sensitivity of 92.31% and a specificity of 98.11%. Overall, or combined, sensitivity and specificity of the in-house-designed RT qPCR assay were 96.08% and 100.00%, respectively. Conclusions The in-house-designed multiplex real-time RT-qPCR kit was more sensitive than the commercial kit for detecting SARS-CoV-2, and the in-house ELISA kit showed acceptable sensitivity and specificity, given its very low cost. The in-house designed kits were far less expensive than the commercial kits. This study demonstrated a broad range of viral loads, which means some infected individuals with low viral loads might be below the limit of detection of commercial assays.
Affiliated Institutions
Related Publications
Evaluation of Advanced Reverse Transcription-PCR Assays and an Alternative PCR Target Region for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus
ABSTRACT First-generation reverse transcription-PCR (RT-PCR) assays for severe acute respiratory syndrome-associated coronavirus (SARS-CoV) gave false-negative results in a cons...
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients
A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly...
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Background Chest CT is used in the diagnosis of coronavirus disease 2019 (COVID-19) and is an important complement to reverse-transcription polymerase chain reaction (RT-PCR) te...
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Abstract Background The emergence of coronavirus disease 2019 (COVID-19) is a major healthcare threat. The current method of detection involves a quantitative polymerase chain r...
Detection of SARS Coronavirus in Patients with Severe Acute Respiratory Syndrome by Conventional and Real-Time Quantitative Reverse Transcription-PCR Assays
Abstract Background: A novel coronavirus (CoV) was recently identified as the agent for severe acute respiratory syndrome (SARS). We compared the abilities of conventional and r...
Publication Info
- Year
- 2025
- Type
- article
- Citations
- 0
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.21203/rs.3.rs-8233598/v1